腸溶性カプセル市場：機能性、ポリマー、メカニズム、流通経路、投与経路、治療領域別-2025年～2030年世界予測

腸溶性カプセル市場は、2023年に6億7,453万米ドルと評価され、2024年には7億1,332万米ドルに達すると予測され、CAGR 5.81％で成長し、2030年には10億163万米ドルに達すると予測されています。

腸溶性カプセル市場には、胃ではなく腸で医薬品有効成分（API）が放出されるように設計された、標的ドラッグデリバリー製品が含まれます。これらのカプセルは、胃酸から敏感なAPIを保護し、薬効を高め、胃腸の副作用を軽減するために極めて重要です。抗生物質、酵素、プロバイオティクス製剤などの医薬品に広く応用されています。最終用途は医薬品と栄養補助食品に及び、主な分野は病院、診療所、オンライン薬局です。市場を牽引しているのは、ターゲットを絞ったドラッグデリバリーシステムに対する需要の高まり、薬剤投与方法の改善を必要とする高齢化、胃腸の健康に対する意識の高まりなどです。カプセルの設計と素材における技術的進歩は、特に生分解性と無毒性のコーティングの開発において、複数の成長機会をもたらしています。新たな機会は個別化医療にあり、腸溶性カプセルは特定の患者のニーズに合わせて調整できるため、精密ドラッグデリバリーの道が開ける。メーカーが直面する課題は、原材料の高コストと厳しい規制要件であり、これが市場成長の妨げとなる可能性があります。さらに、これらのカプセルを製造するための専門的なインフラが必要なことも制約となっています。こうした課題を克服するため、企業は研究開発に投資して費用対効果の高い製造プロセスを革新し、カプセル製造用の生分解性素材を探求することができます。技術革新の最も有望な分野には、複雑な治療レジメンのために順次放出される異なる原薬を収容できるマルチコンパートメントカプセルの開発が含まれます。可変pH条件下での腸溶カプセルの安定性向上のためのナノテクノロジーへのさらなる探究も、競争優位性をもたらす可能性があります。市場の競争は中程度で、主要プレーヤーは市場でのプレゼンスを拡大し、製品ラインアップを充実させるために、M&Aや戦略的提携に注力しています。腸溶性カプセル市場の利害関係者は、進化する消費者の需要の中で成長を維持するために、製品の差別化と厳しい衛生規制への準拠を重視しなければならないです。

市場力学：急速に進化する腸溶性カプセル市場の主要市場インサイトを公開

腸溶性カプセル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界人口における胃腸疾患および障害の有病率の増加
  • 標的薬物送達と有効性向上を目的とした製薬業界における腸溶性カプセルの採用拡大
  • 他のデリバリー方法よりも経口薬物投与を好む消費者の増加
• 市場抑制要因
  • 高品質なゼラチンやその他の原材料の入手可能性が限られているため、サプライチェーンの一貫性が損なわれます。
• 市場機会
  • 腸の健康とウェルネスをターゲットとする栄養補助食品アプリケーションにおけるバイオアベイラビリティ向上のための腸溶性カプセルの活用
  • 製品の品質と性能を高めるカプセル製造工程の技術的進歩
  • 動物用胃腸治療薬の送達を最適化するための、動物用医薬品における腸溶性コーティングカプセルの使用拡大
• 市場の課題
  • 複雑で時間のかかる新製剤の承認プロセスが新製品の市場投入を遅らせる

ポーターの5つの力：腸溶性カプセル市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：腸溶性カプセル市場における外部からの影響の把握

外部マクロ環境要因は、腸溶性カプセル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析腸溶性カプセル市場における競合情勢の把握

腸溶性カプセル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス腸溶性カプセル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、腸溶性カプセル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨腸溶性カプセル市場における成功への道筋を描く

腸溶性カプセル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界人口における消化器疾患および障害の罹患率の増加
    • 標的ドラッグデリバリーと有効性の向上のため、製薬業界で腸溶性カプセルの採用が増加
    • 他の投与方法よりも経口投与を好む消費者が増えている
  • 抑制要因
    • 高品質のゼラチンやその他の原材料の入手が制限され、サプライチェーンの一貫性が損なわれている
  • 機会
    • 腸の健康とウェルネスをターゲットとした栄養補助食品の用途において、腸溶性カプセルを活用してバイオアベイラビリティを向上させる
    • 製品の品質と性能を向上させるカプセル製造プロセスの技術的進歩
    • 動物の胃腸治療の投与を最適化するために獣医学における腸溶性カプセルの使用を拡大する
  • 課題
    • 新しい処方に対する複雑で時間のかかる承認プロセスにより、新製品の市場投入までの時間が遅れる
• 市場セグメンテーション分析
  • ポリマーの種類：優れたpH依存性溶解性により、合成ポリマーは広く使用されています。
  • 用途：薬効を高める腸溶性カプセルが好まれる
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 腸溶性カプセル市場：機能性別

• 遅延放出カプセル
• 即効性カプセル
• 徐放性カプセル

第7章 腸溶性カプセル市場：ポリマー別

• 動物由来
  • ゼラチン
  • シェラック
• 植物由来
  • セルロースアセテートフタレート（CAP）
  • ヒドロキシプロピルメチルセルロース（HPMC）
• 合成由来
  • ポリ（メタクリル酸-メタクリル酸メチル）
  • ポリ酢酸ビニルフタレート（PVAP）

第8章 腸溶性カプセル市場：メカニズム別

• 遅延放出カプセル
• 徐放性カプセル
• 即効性カプセル

第9章 腸溶性カプセル市場：流通経路別

• 病院薬局
• オンラインストア
• 小売薬局

第10章 腸溶性カプセル市場：投与経路別

• 経口
• 直腸

第11章 腸溶性カプセル市場：治療領域別

• 心臓病学
• 糖尿病
• 消化器内科
• 感染症
• 神経学
• 腫瘍学

第12章 南北アメリカの腸溶性カプセル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋の腸溶性カプセル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの腸溶性カプセル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • エボニック、前臨床試験用機能性経口カプセル「EUDRACAP」を発売
• 戦略分析と提言

企業一覧

• 1. ACG Worldwide
• 2. Aenova Group
• 3. Associated Biotech Group
• 4. Biocaps Enterprises
• 5. Bright Pharma Caps Inc.
• 6. Captek Softgel International Inc.
• 7. Chemcaps Limited
• 8. Coating Place Inc.
• 9. Farmacapsulas S.A
• 10. FUJI Capsule Co., Ltd.
• 11. GELITA AG
• 12. GMP Laboratories of America Inc.
• 13. Hunan ER-Kang Pharmaceutical Co., Ltd.
• 14. Lonza Group AG
• 15. Mitsubishi Chemical Holdings Corporation
• 16. Natural Capsules Limited
• 17. Nectar Lifesciences Ltd.
• 18. NextPharma Technologies
• 19. Qualicaps by Roquette
• 20. Roxlor LLC
• 21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. ENTERIC CAPSULE MARKET RESEARCH PROCESS
• FIGURE 2. ENTERIC CAPSULE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENTERIC CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. ENTERIC CAPSULE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. ENTERIC CAPSULE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENTERIC CAPSULE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENTERIC CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENTERIC CAPSULE MARKET DYNAMICS
• TABLE 7. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DELAYED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SUSTAINED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SHELLAC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY CELLULOSE ACETATE PHTHALATE (CAP), BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLY(METHACRYLIC ACID-CO-METHYL METHACRYLATE), BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYVINYL ACETATE PHTHALATE (PVAP), BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DELAYED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 70. CANADA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 71. CANADA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 72. CANADA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 73. CANADA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 74. CANADA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 75. CANADA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 76. CANADA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. CANADA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. CANADA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 117. CHINA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 118. CHINA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 119. CHINA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 120. CHINA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 121. CHINA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 122. CHINA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 123. CHINA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. CHINA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. CHINA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 126. INDIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 127. INDIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 128. INDIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 129. INDIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 130. INDIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 131. INDIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 132. INDIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. INDIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 134. INDIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 149. JAPAN ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 158. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 165. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 167. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 174. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 176. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 181. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 189. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 190. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 192. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 194. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 198. THAILAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 199. THAILAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 201. THAILAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 203. THAILAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 207. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 208. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 210. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 212. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 226. DENMARK ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 227. DENMARK ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 229. DENMARK ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 231. DENMARK ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 235. EGYPT ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 236. EGYPT ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 238. EGYPT ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 240. EGYPT ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 244. FINLAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 245. FINLAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 247. FINLAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 249. FINLAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 253. FRANCE ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 254. FRANCE ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 256. FRANCE ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 258. FRANCE ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 262. GERMANY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 263. GERMANY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 265. GERMANY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 267. GERMANY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 271. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 272. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 274. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 276. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 280. ITALY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 281. ITALY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 282. ITALY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 283. ITALY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 284. ITALY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 285. ITALY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 286. ITALY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 287. ITALY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 288. ITALY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 289. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 290. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 291. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 292. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 294. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 298. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 299. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 300. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 301. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 303. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 307. NORWAY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 308. NORWAY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 309. NORWAY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 310. NORWAY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 311. NORWAY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 312. NORWAY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 314. NORWAY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 316. POLAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 317. POLAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 318. POLAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 319. POLAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 320. POLAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 321. POLAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 322. POLAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 323. POLAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 324. POLAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 325. QATAR ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 326. QATAR ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 327. QATAR ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 328. QATAR ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 329. QATAR ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 330. QATAR ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 331. QATAR ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 332. QATAR ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 333. QATAR ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 334. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 335. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 336. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 337. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 338. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 339. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 340. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 341. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 342. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 343. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 344. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 345. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 346. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
• TABLE 347. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
• TABLE 348. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
• TABLE 349. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 350. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 351. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 352. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
• TABLE 353. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 354. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
• TABLE 355. S

The Enteric Capsule Market was valued at USD 674.53 million in 2023, expected to reach USD 713.32 million in 2024, and is projected to grow at a CAGR of 5.81%, to USD 1,001.63 million by 2030.

The enteric capsule market encompasses products designed for targeted drug delivery, ensuring that active pharmaceutical ingredients (APIs) are released in the intestine rather than the stomach. These capsules are crucial for protecting sensitive APIs from stomach acid, enhancing drug efficacy, and reducing gastrointestinal side effects. They are widely applied in pharmaceuticals for medications like antibiotics, enzymes, and probiotic formulations. The end-use scope extends to pharmaceuticals and dietary supplements, with key sectors being hospitals, clinics, and online pharmacies. The market is driven by the escalating demand for targeted drug delivery systems, an aging population necessitating improved drug administration methods, and increased awareness of gastrointestinal health. Technological advancements in capsule design and materials present multiple growth opportunities, particularly in developing biodegradable and non-toxic coatings. An emerging opportunity lies in personalized medicine, where enteric capsules can be tailored for specific patient needs, thus opening avenues for precision drug delivery. A challenge that manufacturers face is the high cost of raw materials and stringent regulatory requirements, which can hinder market growth. Additionally, the need for specialized infrastructure to manufacture these capsules also poses a limitation. To overcome these challenges, businesses can invest in research and development to innovate cost-effective manufacturing processes and explore biodegradable materials for capsule production. The most promising areas of innovation include the development of multi-compartment capsules, which can house different APIs released sequentially for complex therapeutic regimens. Further exploration into nanotechnology for enhanced stability of enteric capsules in variable pH conditions could also offer a competitive edge. The market is moderately competitive, with key players focusing on mergers, acquisitions, and strategic partnerships to expand market presence and enhance product offerings. Stakeholders in the enteric capsule market must emphasize product differentiation and compliance with stringent health regulations to sustain growth amid evolving consumer demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enteric Capsule Market

The Enteric Capsule Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of gastrointestinal diseases and disorders among global population
  • Growing adoption of enteric capsules in pharmaceutical industry for targeted drug delivery and improved efficacy
  • Rising consumer preference for oral drug administration over other delivery methods
• Market Restraints
  • Limited availability of high-quality gelatin and other raw materials disrupt supply chain consistency
• Market Opportunities
  • Leveraging enteric capsules for improved bioavailability in nutraceutical applications targeting gut health and wellness
  • Technological advancements in capsule manufacturing processes to enhance product quality and performance
  • Expanding the use of enteric-coated capsules in veterinary medicine to optimize the delivery of gastrointestinal treatments for animals
• Market Challenges
  • Intricate and time-consuming approval processes for new formulations delay time-to-market for new products

Porter's Five Forces: A Strategic Tool for Navigating the Enteric Capsule Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enteric Capsule Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enteric Capsule Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enteric Capsule Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enteric Capsule Market

A detailed market share analysis in the Enteric Capsule Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enteric Capsule Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enteric Capsule Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enteric Capsule Market

A strategic analysis of the Enteric Capsule Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Capsule Market, highlighting leading vendors and their innovative profiles. These include ACG Worldwide, Aenova Group, Associated Biotech Group, Biocaps Enterprises, Bright Pharma Caps Inc., Captek Softgel International Inc., Chemcaps Limited, Coating Place Inc., Farmacapsulas S.A, FUJI Capsule Co., Ltd., GELITA AG, GMP Laboratories of America Inc., Hunan ER-Kang Pharmaceutical Co., Ltd., Lonza Group AG, Mitsubishi Chemical Holdings Corporation, Natural Capsules Limited, Nectar Lifesciences Ltd., NextPharma Technologies, Qualicaps by Roquette, Roxlor LLC, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Enteric Capsule Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Functionality, market is studied across Delayed-Release Capsules, Immediate-Release Capsules, and Sustained-Release Capsules.
• Based on Polymer, market is studied across Animal Origin, Plant-based, and Synthetic Origin. The Animal Origin is further studied across Gelatin and Shellac. The Plant-based is further studied across Cellulose Acetate Phthalate (CAP) and Hydroxypropyl Methylcellulose (HPMC). The Synthetic Origin is further studied across Poly(methacrylic acid-co-methyl methacrylate) and Polyvinyl Acetate Phthalate (PVAP).
• Based on Mechanism, market is studied across Delayed-Release Capsules, Extended-Release Capsules, and Immediate-Release Capsules.
• Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
• Based on Route of Administration, market is studied across Oral and Rectal.
• Based on Therapeutic Area, market is studied across Cardiology, Diabetes, Gastroenterology, Infectious Diseases, Neurology, and Oncology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of gastrointestinal diseases and disorders among global population
    • 5.1.1.2. Growing adoption of enteric capsules in pharmaceutical industry for targeted drug delivery and improved efficacy
    • 5.1.1.3. Rising consumer preference for oral drug administration over other delivery methods
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of high-quality gelatin and other raw materials disrupt supply chain consistency
  • 5.1.3. Opportunities
    • 5.1.3.1. Leveraging enteric capsules for improved bioavailability in nutraceutical applications targeting gut health and wellness
    • 5.1.3.2. Technological advancements in capsule manufacturing processes to enhance product quality and performance
    • 5.1.3.3. Expanding the use of enteric-coated capsules in veterinary medicine to optimize the delivery of gastrointestinal treatments for animals
  • 5.1.4. Challenges
    • 5.1.4.1. Intricate and time-consuming approval processes for new formulations delay time-to-market for new products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Polymer Type: Wide use of synthetic polymers owing to their excellent pH-dependent solubility
  • 5.2.2. Applications: Preference for enteric capsules due to their enhancing drug efficacy
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Enteric Capsule Market, by Functionality

• 6.1. Introduction
• 6.2. Delayed-Release Capsules
• 6.3. Immediate-Release Capsules
• 6.4. Sustained-Release Capsules

7. Enteric Capsule Market, by Polymer

• 7.1. Introduction
• 7.2. Animal Origin
  • 7.2.1. Gelatin
  • 7.2.2. Shellac
• 7.3. Plant-based
  • 7.3.1. Cellulose Acetate Phthalate (CAP)
  • 7.3.2. Hydroxypropyl Methylcellulose (HPMC)
• 7.4. Synthetic Origin
  • 7.4.1. Poly(methacrylic acid-co-methyl methacrylate)
  • 7.4.2. Polyvinyl Acetate Phthalate (PVAP)

8. Enteric Capsule Market, by Mechanism

• 8.1. Introduction
• 8.2. Delayed-Release Capsules
• 8.3. Extended-Release Capsules
• 8.4. Immediate-Release Capsules

9. Enteric Capsule Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Stores
• 9.4. Retail Pharmacies

10. Enteric Capsule Market, by Route of Administration

• 10.1. Introduction
• 10.2. Oral
• 10.3. Rectal

11. Enteric Capsule Market, by Therapeutic Area

• 11.1. Introduction
• 11.2. Cardiology
• 11.3. Diabetes
• 11.4. Gastroenterology
• 11.5. Infectious Diseases
• 11.6. Neurology
• 11.7. Oncology

12. Americas Enteric Capsule Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Enteric Capsule Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Enteric Capsule Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Evonik launches EUDRACAP preclinic functional oral capsule for preclinical trials
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ACG Worldwide
• 2. Aenova Group
• 3. Associated Biotech Group
• 4. Biocaps Enterprises
• 5. Bright Pharma Caps Inc.
• 6. Captek Softgel International Inc.
• 7. Chemcaps Limited
• 8. Coating Place Inc.
• 9. Farmacapsulas S.A
• 10. FUJI Capsule Co., Ltd.
• 11. GELITA AG
• 12. GMP Laboratories of America Inc.
• 13. Hunan ER-Kang Pharmaceutical Co., Ltd.
• 14. Lonza Group AG
• 15. Mitsubishi Chemical Holdings Corporation
• 16. Natural Capsules Limited
• 17. Nectar Lifesciences Ltd.
• 18. NextPharma Technologies
• 19. Qualicaps by Roquette
• 20. Roxlor LLC
• 21. Thermo Fisher Scientific Inc.